International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Insulin and Adjunctive Treatments in Children and Adolescents with Diabetes
Recommendations
As issued by the authors
Updated recommendations on principles of intensive insulin regimens, incl. more intensive forms of MDI with new-generation faster-acting and ultra-long-acting insulins
Summary of adjunctive medications used alongside insulin: pramlintide, metformin, GLP-1 RA and sodium-glucose cotransporter inhibitors
Key considerations on access to insulin and affordability, so that all persons with diabetes who need insulin can obtain it without financial hardship
Original publication
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Insulin and Adjunctive Treatments in Children and Adolescents with Diabetes. Horm Res Paediatr. Published 30 January 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →